1.A New ent-Kaurane Glycoside from the Stems of Acanthopanax gracilistylus
Chinese Herbal Medicines 2010;02(3):168-169
Objective To study the chemical constituents from the stems of Acanthopanax gracilistylus.Methods Thechemical constituents of the plant were isolated and puried by column chromatography and their structures wereelucidated on the basis of physicochemical properties and spectral data.Results A new ent-kaurane glycoside,named kaurane acid glycoside A { 16α,17-dihydroxy-ent-kauran-19-oic 19-[β-D-glucopyranosyl-(1→2)-β-Dglucopyranosyl]ester}(1),was isolated from the n-butanol part.Conclusion Compound 1 is a new one.
2.Research of mechanism jinxueyuan granules increased saliva secretion of xerostomia model rats.
Yan LIU ; Hong-Yi WANG ; Xian QIAN
China Journal of Chinese Materia Medica 2014;39(11):2112-2116
To analyze the specific mechanism of Jinxueyuan granules, the relationship between the Jinxueyuan granules increased the saliva secretion of xerostomia model SD rats and excitement of receptors were studied in this experiment. In the study, three groups of xerostomia model rats were successfully established by using M-receptor blockers-4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) and atropine, or adrenergic receptor blocker phentolamine; after the modeling, the medicine Jinxueyuan granules were gavaged. According to the clinical dose of Jinxueyuan granules and SD rats body surface area, the rats in atropine group were divided three dose groups respectively, namely low, medium and high dose of Jinxueyuan granules groups. The 4-DAMP group and phentolamine group were gavaged medium dose of Jinxueyuan granules. And the amount of salivary secretion for 150 minutes in all groups continuously were measured, and the effect of Jinxueyuan granules increased salivation and the relationship between characteristics and the receptors were observed; and submandibular gland tissue of the rats was isolated, then the effect of Jinxueyuan Granules for expression of the water channel protein aquaporin-5 (AQP5) in submandibular gland cells was analyzed by the Western blot technology. It was found that the saliva secretion of Jinxueyuan Granules groups was increased significantly, and compared with the saline control group, phentolamine group, 4-DAMP group and atropine group, difference was significant, P < 0.05. There was no significant difference between the low-dose of Jinxueyuan granules group and the saline group, but the medium dose of Jinxueyuan granules group had a significant difference, compared with the saline group (P < 0.05). In the time distribution of increasing saliva secretion, there was a significant difference between the saline and Jinxueyuan granules group in the saliva secretion (P < 0.05). After administration of Jinxueyuan granules, the expression of AQP5 protein in the submandibular gland cells expressing of treatment groups was increased, and compared with the blocker groups, there was a significant difference, P < 0.05. Except the atropine group, there was no significant difference in Jinxueyuan granules relieving the inhibition induced by blocks in phentolamine group and 4-DAMP group, compared with the saline group. Compared the AQP5 expression in three blockers groups, there was no significant difference in the efficacy of Jinxueyuan granules between phentolamine group and 4-DAMP group; but there was a significant difference between the atropine group and other groups (P < 0.05). Therefore, it was considered that the mechanism of Jinxueyuan granules increasing saliva secretion (effectiveness of nourishing Yin and generating body fluid ) possibly through the pathway mediated by muscarinic M receptor, especially M3 receptor, or adrenergic receptor, and increased expression of salivary gland AQP5 membrane, and then stimulate saliva production.
Animals
;
Disease Models, Animal
;
Drugs, Chinese Herbal
;
administration & dosage
;
Humans
;
Male
;
Rats
;
Saliva
;
secretion
;
Salivary Glands
;
drug effects
;
secretion
;
Xerostomia
;
drug therapy
;
metabolism
3.Acute benign myositis--a case report.
Xian QIAN ; Shuang-jun LU ; Feng GUO
Chinese Journal of Pediatrics 2005;43(10):732-732
Acute Disease
;
Adolescent
;
Humans
;
Male
;
Myositis
4.An experimental study on osseo-induction and biodegradation performances of three types of injectable and degradable calcium phosphate cement
Bo BAI ; Xian-Pei WU ; Qian XU ;
Chinese Journal of Orthopaedic Trauma 2004;0(06):-
Objective To compare the osseo-induction and biodegradation performances of three types of injectable and degradable calcium phosphate cement (CPC) so as to find out a better bone substitute. Methods Three types of injectable and degradable CPC were respectively implanted into the bilateral tibias of 24 New Zealand rabbits: pure CPC (Group A), CPC added with Zinc and Strontiumions (Group B), and CPC with composite rhBMP-2 (Group C) . Their systematic and local reactions in implanted region were closely observed. The degra- dation and osseo-induction performances were compared macroscopically, microscopically and by CT scan to find out the one that could best meet clinical needs. Tissue slices were sampled and photographed four, eight and 16 weeks after operation. Five photographs were selected in each group and at each time points for computer software (Image Pro Plus 5.1) processing to calculate the percentages of bone in the images of postoperative slices. Results In Groups A and B, new bone was found to form slowly and little by little, and the ossification was not synchronous with the material degradation. In Group C, however, new bone was observed to form early and massively, and the os- sification was almost synchronous with the material degradation. In Groups A, B and C, the percentage of bone in the images of postoperative slices was (41.7?16.6)%, (31. 2?12.2)% and (71.7?21.0)% respectively. The bone percentage in CPC with composite rhBMP-2 was significantly higher than that in the other two types of CPC (P<0.01 ). Conclusion The injectable and degradable CPC with composite rhBMP-2 is more suitable for clinical use, because it can induce early new bone formation and synchronous biodegradation.
6.Solitary giant osteochondroma of femur lesser trochanter: a case report.
Chong-yang WANG ; Wei-qian WU ; Ming-xian LI
China Journal of Orthopaedics and Traumatology 2015;28(5):461-463
Adult
;
Bone Neoplasms
;
pathology
;
surgery
;
Femur
;
pathology
;
surgery
;
Humans
;
Male
;
Osteochondroma
;
pathology
;
surgery
;
Young Adult
8.Clinical and etiological analyses of acute lower respiratory tract infections in children in Kunming area.
Qian WU ; Lin-xian NI ; Yang-fang LI
Chinese Journal of Pediatrics 2008;46(6):468-469
Adolescent
;
Child
;
Child, Preschool
;
China
;
epidemiology
;
Female
;
Humans
;
Incidence
;
Infant
;
Male
;
Respiratory Tract Infections
;
epidemiology
;
virology
;
Virus Diseases
;
epidemiology
9.Posterior circulation infarction: distribution of lesions and CT angiography
Li JI ; Xian LIU ; Yuqiang SONG ; Qian WNAG
International Journal of Cerebrovascular Diseases 2014;22(2):93-98
Objective To investigate the correlation between the distribution of lesions on MRI and the findings of computerized tomography angiography (CTA) in patients with posterior circulation infarction.Methods Patients with acute posterior circulation infarction were enrolled in the study.The sites of the infarcts were divided into proximal,middle and distal infarctions according to the results of MRI.All the patients received head and neck CTA.The correlation between the distribution of posterior circulation infarcts and the sites of vertebrobasilar system lesions was analyzed.Results A total of 203 patients with acute posterior circulation infarction were enrolled.Their primary clinical symptoms and signs were unilateral limb weakness (n =77,37.93%),dizziness (n =129,63.55%),dysarthria (n =31,15.27%),nausea and vomiting (n =61,30.05%),headache (n =79,38.92%),gait abnormal (n =50,24.63%),nystagmus (n=34,16.75%),and ataxia (n=21,10.34%).Proximal infarction (n=35,17.24%):medullary infarction (n =28,13.79%),posterior inferior cerebellar artery infarction (n =7,3.45%); middle infarction (n =95,46.79%):pontine infarction (n =80,39.4%),anterior inferior cerebellar infarction (n =15,7.39%); distal infarction (n=73,35.96%):middle cerebral infarction (n=6,2.96%),superior cerebellar infarction (n =16,7.88%),thalamic infarction (n =34,(16.75%),occipital lobe infarction (n =10,4.93%),temporal lobe infarction (n =7,3.44%).Extracranial vertebral artery lesions were most common in the distal infarction group.It reached 53.42%,and was significantly higher than 22.86% in the proximal infarction group (P =0.003) and 33.68% in the middle infarction group (P =0.010).Intracranlal vertebral artery lesions were most common in the proximal infarction group.It reached 57.14%,and then followed by the middle infarction (41.05%).They were all significantly higher than 15.07% in the distal infarction group (all P =0.000).Basilar artery lesions were most common in the middle infarction group.It reached 20.00% and was significantly higher than 4.11% in the distal infarction group (P=0.002).Posterior cerebral artery lesions were most common in the distal infarction group.It reached 27.40% and was significantly higher than 5.71% in the proximal infarction group (P =0.009) and 5.26% in the middle infarction group (P=0.000).Conclusions The range of vascular lesions of the distribution of lesions shown on MRI and the findings of CTA on vertebrobasilar artery system in patients with posterior circulation infarction had some connection.During the proximal and middle infarctions,the possibility of having intracranial vertebral artery lesions was greater; during the distal infarction,the possibility of having extracranial vertebral artery and posterior cerebral artery lesions was greater.
10. Pharmaceutical care for nutrition support therapy in large area burn patients
Chinese Pharmaceutical Journal 2016;51(6):502-505
OBJECTIVE: To explore the keypoints and methods of pharmaceutical care provided by clinical pharmacists in nutritional support for patients with severe burn. METHODS: Through summarizing the pharmaceutical care process in nutrition support therapy in large area burn patients, the contents of pharmaceutical care including the requirements for thermal energy and nutrients, choice of drugs, nutrition support pathway, complication prevention, application of other special nutrients and so on were described. RESULTS: Through pharmaceutical care, the nutritional support regimen was adjusted, which improved the safety and effectiveness of drug treatment and laid the foundation for related treatments for patients with severe burn. CONCLUSION: Nutritional support is one of the important measures in the treatment of severe burn patients. Pharmaceutical care can improve the standardization and effectiveness of nutritional support treatment. At the same time, the value of clinical pharmacists can be reflected through collaborative service with doctors and nurses.